Loralie J. Langman, PhDMayo Clinic

Dr. Lorelie Langman completed her PhD in Laboratory Medicine and Pathology at the University of Alberta Canada. She completed her Clinical Chemistry training at the University of Toronto, specializing in Forensic Toxicology and Molecular Genetics. She is certified with the Canadian Academy of Clinical Biochemistry and is the first individual to have achieved Diplomat status with the American Board of Clinical Chemistry in all three disciplines- Clinical Chemistry, Molecular Diagnostics, and Toxicological Chemistry). She is also a Fellow with the American Board of Forensic Toxicology. Dr. Langman is a member of and serves on committees for several professional organizations including: The Society of Forensic Toxicologists, the American Academy of Forensic Sciences, the Clinical and Laboratory Standards Institute the Canadian Society of Clinical Chemists, The International Association of Forensic Toxicologists, the American Association for Clinical Chemistry, the Academy of the AACC (formerly NACB) where she is their current President, the International Federation Of Clinical Chemistry And Laboratory Medicine. She is the President of The International Association of Therapeutic Drug Monitoring and Clinical Toxicology. She is currently the Director of the Clinical and Forensic Toxicology Laboratory, Clinical Mass Spectroscopy Laboratory, and a Consultant for the Personal Genomics Laboratory, Mayo Clinic Rochester, MN and Professor of Laboratory Medicine an Pathology, Mayo Clinic College of Medicine She has over 60 peer reviewed publications and over 125 abstracts/presentations at National and International meetings. She has authored 20 book chapters and co-authored 5 books.


Urine, Oral Fluid, or Serum? Interpretation of Interactive Case Studies Using Point of Care (POC) and Laboratory-Based Tests (302)

Director, Clinical and Forensic Toxicology Laboratory
Rochester, MN